The CRA II is responsible for managing site activities from start-up through close-out for Phase I–IV clinical trials.
Base: $84,000.00 - $170,900.00 annualized; Bonus/Equity: Incentive plans and bonuses may be offered; Benefits: Health, wellness, and other benefits included
Must-have
Nice-to-have
Not specified